Comprehensive Two- and Three-Dimensional RNAi Screening Identifies PI3K Inhibition as a Complement to MEK Inhibitor AS703026 for Combination Treatment of Triple-Negative Breast Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comprehensive Two- and Three-Dimensional RNAi Screening Identifies PI3K Inhibition as a Complement to MEK Inhibitor AS703026 for Combination Treatment of Triple-Negative Breast Cancer

Published:2015 Issue:12 Volume:6 Page:1306-1319
ISSN:1837-9664
Container-title:Journal of Cancer
language:en
Short-container-title:J. Cancer

Author:

Lee Jangsoon,Galloway Rachael,Grandjean Geoff,Jacob Justin,Humphries Juliane,Bartholomeusz Chandra,Goodstal Samantha,Lim Bora,Bartholomeusz Geoffrey,Ueno Naoto T.,Rao Arvind

Publisher

Ivyspring International Publisher

Subject

Oncology

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the role of PI3K/AKT/mTOR inhibitors in hormone-related cancers: A focus on breast and prostate cancer;Biomedicine & Pharmacotherapy;2023-12

2. MicroRNA-Based Discovery of Biomarkers, Therapeutic Targets, and Repositioning Drugs for Breast Cancer;Cells;2023-07-23

3. Quiescent Cancer Cells—A Potential Therapeutic Target to Overcome Tumor Resistance and Relapse;International Journal of Molecular Sciences;2023-02-13

4. ONC201 and an MEK Inhibitor Trametinib Synergistically Inhibit the Growth of Triple-Negative Breast Cancer Cells;Biomedicines;2021-10-07

5. Small-Molecule Drug Discovery in Triple Negative Breast Cancer: Current Situation and Future Directions;Journal of Medicinal Chemistry;2021-03-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP